Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-09 Sale |
2021-02-09 9:15 pm |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
390 | $7.66 | $2,987 | 9,833 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-09 9:12 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
778 | $7.66 | $5,959 | 8,298 (Direct) |
View |
| 2020-08-28 Sale |
2020-09-03 9:47 pm |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
7,360 | $4.0099 | $29,513 | 118,075 (Indirect Direct) |
View |
| 2020-08-26 Sale |
2020-08-28 9:09 pm |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
7,640 | $4.1493 | $31,701 | 125,435 (Indirect Direct) |
View |
| 2020-06-19 Purchase |
2020-06-23 4:27 pm |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
1,850 | $4.22 | $7,807 | 9,153 (Direct) |
View |
| 2020-06-19 Purchase |
2020-06-23 4:23 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
6,000 | $4.27 | $25,620 | 7,291 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-28 Option Award |
2021-04-29 8:13 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:11 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | Lucas Svetlana Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:08 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | Gross Jane A Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:06 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:02 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-02-04 Option Award(A) |
2021-03-09 4:29 pm |
N/A 2031-02-04 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
112,469 | $0 | 112,469 (Direct) |
View |
| 2021-02-06 Exercise |
2021-02-09 9:15 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
892 | $0 | 9,833 (Direct) |
View |
| 2021-02-06 Exercise |
2021-02-09 9:12 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
1,785 | $0 | 8,298 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 8:18 pm |
N/A 2031-02-04 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 8:13 pm |
N/A 2031-02-04 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
45,000 | $0 | 45,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 8:08 pm |
N/A 2031-02-04 |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |